These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9479447)

  • 21. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
    Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
    J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remarkable remote chiral recognition in a reaction mediated by a catalytic antibody.
    D'Souza LJ; Gigant B; Knossow M; Green BS
    J Am Chem Soc; 2002 Mar; 124(10):2114-5. PubMed ID: 11878955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct hydroxide attack is a plausible mechanism for amidase antibody 43C9.
    Chong LT; Bandyopadhyay P; Scanlan TS; Kuntz ID; Kollman PA
    J Comput Chem; 2003 Sep; 24(12):1371-7. PubMed ID: 12868101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity.
    Ruzheinikov SN; Muranova TA; Sedelnikova SE; Partridge LJ; Blackburn GM; Murray IA; Kakinuma H; Takahashi-Ando N; Shimazaki K; Sun J; Nishi Y; Rice DW
    J Mol Biol; 2003 Sep; 332(2):423-35. PubMed ID: 12948492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.
    Sonkaria S; Boucher G; Flórez-Olvarez J; Said B; Hussain S; Ostler EL; Gul S; Thomas EW; Resmini M; Gallacher G; Brocklehurst K
    Biochem J; 2004 Jul; 381(Pt 1):125-30. PubMed ID: 15053743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunological evolution of catalysis.
    Patten PA; Gray NS; Yang PL; Marks CB; Wedemayer GJ; Boniface JJ; Stevens RC; Schultz PG
    Science; 1996 Feb; 271(5252):1086-91. PubMed ID: 8599084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From molecular diversity to catalysis: lessons from the immune system.
    Schultz PG; Lerner RA
    Science; 1995 Sep; 269(5232):1835-42. PubMed ID: 7569920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary chemistry: getting there from here.
    Joyce GF
    Science; 1997 Jun; 276(5319):1658-9. PubMed ID: 9206829
    [No Abstract]   [Full Text] [Related]  

  • 33. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological origins of binding and catalysis in a Diels-Alderase antibody.
    Romesberg FE; Spiller B; Schultz PG; Stevens RC
    Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody.
    Zhang X; Deng Q; Yoo SH; Houk KN
    J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural evidence for a programmed general base in the active site of a catalytic antibody.
    Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridoxal-5'-phosphate-dependent catalytic antibodies.
    Gramatikova S; Mouratou B; Stetefeld J; Mehta PK; Christen P
    J Immunol Methods; 2002 Nov; 269(1-2):99-110. PubMed ID: 12379355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inactivation of a catalytic antibody by p-nitrophenyl esters.
    Gigant B; Charbonnier JB; Golinelli-Pimpaneau B; Zemel RR; Eshhar Z; Green BS; Knossow M
    Eur J Biochem; 1997 Jun; 246(2):471-6. PubMed ID: 9208940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.